Geoffrey Rosevear, NURSE PRACTITIONER
Family Nurse Practitioner in Johnson City, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 210,832 in Family Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Geoffrey Rosevear, NURSE PRACTITIONER reported a CMS MIPS final score of 88.5/100 - above the 83.5 national average - and filed 8,694 Medicare Part D claims in 2023.
- 88.5/100
- MIPS score · +5 vs avg
- 9K
- Part D claims, 2023
- 83%
- generic prescribing
- $332.77
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1225364854 · Family Nurse Practitioner
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-ABOVE · RX-MID · BOOK-MID · PHOTO-FINISH
- NPI-10 1225364854
- ENUM-MID 2009
- TAX-MEGA 211K Family Nurse
- MIPS-ABOVE 88.5/100
- RX-MID 8,694
- BOOK-MID 12,508 in New York
- PHOTO-FINISH Julie Angel · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Rosevear · this …
Rosevear · this provider
88.5 MIPS pts
- Katie Hood · hig…
Katie Hood
88.5 MIPS pts
- Julie Angel · near
Julie Angel
88.5 MIPS pts
- Jacqueline Crost…
Jacqueline Croston
88.5 MIPS pts
- Abby Hanson · near
Abby Hanson
88.5 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Geoffrey Rosevear, NURSE PRACTITIONER's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
89 ≥ 54th percentile 54% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Geoffrey Rosevear, NURSE PRACTITIONER sits
This provider among family nurse practitioner peers
Across the 26,556 family nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Geoffrey Rosevear, NURSE PRACTITIONER writes more Part D claims than 99% of them and scores higher on MIPS quality than 55% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one family nurse practitioner peer from a representative sample of 60; the gold marker is Geoffrey Rosevear, NURSE PRACTITIONER. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Geoffrey Rosevear, NURSE PRACTITIONER?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Family Nurse Practitioner compares to other specialties among New York providers
Family Nurse Practitioner ranks #14 among New York's specialties (2.3% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Family Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Geoffrey Rosevear, NURSE PRACTITIONER's 2023 MIPS final score plotted against the Family Nurse Practitioner national average
- MIPS Final Score
- 88.5/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Family Nurse Practitioner US NPIs
88.5/100 MIPS final score - 5.0 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Nurse Practitioner. Quality dim: 78.4. Cost dim: 76.8.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1225364854 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Credentials | NURSE PRACTITIONER |
| Gender | Male |
| NPI Issued | 11/02/2009 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Geoffrey Rosevear, NURSE PRACTITIONER's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1225364854 is the unique 10-digit identifier CMS uses to link Rosevear across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Geoffrey Rosevear, NURSE PRACTITIONER. Source: openpaymentsdata.cms.gov.
Total received
$333
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Geoffrey Rosevear, NURSE PRACTITIONER. To verify Geoffrey Rosevear, NURSE PRACTITIONER's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
17% brand-name claims vs 83% generic, on 8,694 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 23,279
- Total Day Supply
- 693,644
- Brand vs Generic
- 17% brand / 83% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $211K
- Antibiotic Claims
- 13
Patient Demographics
- Average Patient Age
- 74.7 years
- Avg HCC Risk Score
- 1.45
- Gender Split
- 43% female / 57% male
- Age Distribution
- <65: 162, 65-74: 742, 75-84: 682, 85+: 257
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Geoffrey Rosevear, NURSE PRACTITIONER prescribes most
Top Medicare Part D drugs by claim count, 2023
- Metoprolol Succinate
Metoprolol Succinate
1,016 claims
- Atorvastatin Calcium
Atorvastatin Calcium
914 claims
- Clopidogrel
Clopidogrel
710 claims
- Eliquis
Eliquis
587 claims
- Carvedilol
Carvedilol
526 claims
- Entresto 396
Entresto
396 claims
- Amlodipine Besylate 384
Amlodipine Besylate
384 claims
- Isosorbide Mononit… 298
Isosorbide Mononitrate Er
298 claims
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 1,016 |
| Atorvastatin Calcium | 914 |
| Clopidogrel Clopidogrel Bisulfate | 710 |
| Eliquis Apixaban | 587 |
| Carvedilol | 526 |
| Entresto Sacubitril/Valsartan | 396 |
| Amlodipine Besylate | 384 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 298 |
| Furosemide | 272 |
| Rosuvastatin Calcium | 223 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How Geoffrey Rosevear, NURSE PRACTITIONER fits within the Family Nurse Practitioner landscape nationally.
Geoffrey Rosevear, NURSE PRACTITIONER's 8,694 claims are above the specialty average of 1,222.
Nationwide Family Nurse Practitioner peers with similar MIPS or enrollment year
Two federal-record peer sets for Rosevear, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (88.5 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Nurse Practitioner Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Rosevear.
One of 12,508 Family Nurse Practitioner providers enrolled in New York, 5 are shown here.
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Frequently Asked Questions
What is Geoffrey Rosevear, NURSE PRACTITIONER's specialty? ▼
How much does Geoffrey Rosevear, NURSE PRACTITIONER prescribe under Medicare Part D? ▼
What is Geoffrey Rosevear, NURSE PRACTITIONER's Medicare quality score? ▼
Where is Geoffrey Rosevear, NURSE PRACTITIONER located? ▼
What is Geoffrey Rosevear, NURSE PRACTITIONER's NPI number? ▼
Does Geoffrey Rosevear, NURSE PRACTITIONER prescribe more brand-name or generic drugs? ▼
How many Family Nurse Practitioner providers are there in the US? ▼
What drugs does Geoffrey Rosevear, NURSE PRACTITIONER prescribe most often? ▼
Does Geoffrey Rosevear, NURSE PRACTITIONER accept Medicare? ▼
How can I verify Geoffrey Rosevear, NURSE PRACTITIONER's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.